Lexaria Bioscience Corp.·4

Sep 2, 1:49 PM ET

DOCHERTY JOHN MARTIN 4

4 · Lexaria Bioscience Corp. · Filed Sep 2, 2021

Insider Transaction Report

Form 4
Period: 2021-09-01
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
  • Award

    Stock Options

    2021-09-01+15,00064,668 total
    Exercise: $6.23From: 2021-09-01Exp: 2026-09-01Common Shares (15,000 underlying)
Holdings
  • Stock Options

    Exercise: $5.31From: 2021-04-26Exp: 2026-04-26Common Shares (18,000 underlying)
    31,334
  • Stock Options

    Exercise: $7.08From: 2021-06-08Exp: 2026-06-08Common Shares (18,334 underlying)
    49,668
  • common shares

    (indirect: Private Holding Company)
    54,075
  • Stock Options

    Exercise: $9.60From: 2020-04-23Exp: 2025-04-23Common Shares (13,334 underlying)
    13,334

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT